February 13th 2025
Enabling up to 80 percent faster MRI scan times, the SubtleHD software is included in the newly launched AI software suite Subtle-Elite.
New Study Shows Link Between COVID-19 and Elevated Risks for Neurological Disorders
June 25th 2022Emerging research showed that patients with COVID-19 had 3.5 times the risk for developing Alzheimer’s disease and 2.6 times the risk for Parkinson’s disease in comparison to those who did not have COVID-19.
Could an MRI-Based Machine Learning Model Facilitate Enhanced Detection of Alzheimer's Disease?
June 22nd 2022New research suggests that an emerging predictive biomarker, derived from a combination of magnetic resonance imaging (MRI) brain scans and a machine learning algorithm, has significantly greater accuracy than previously established measurements for diagnosing Alzheimer’s disease.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
Iodinated Contrast Media: 15 Recommendations for Addressing the Shortage
May 12th 2022Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.
Issues and Answers With Outsourced Teleradiology Night Coverage
April 28th 2022While there can be an array of challenges in outsourcing night coverage to teleradiology service providers, due diligence with contract terms can help mitigate costs and increase flexibility if radiology practices decide to switch teleradiology providers down the line.
Multicenter Study Assesses Intrasaccular Flow Disruption for Treating Sidewall Aneurysms
April 19th 2022Emphasizing the proper diagnostic characterization of sidewall aneurysms, the authors of a new study found no significant differences in occlusion status or complications when they compared the approved use of intrasaccular flow disruption for bifurcation aneurysms to off-label treatment of sidewall aneurysms.